Vistagen Therapeutics VTGN Earnings Call Transcripts

NASDAQ VTGN
$0.19 -0.01 (-5.00%)
At close: Nov 19, 2026 · 4:00 PM EST
2 earnings calls on file for Vistagen Therapeutics, from Q2 2026 to Q3 2026. Each transcript opens in a new tab.
Latest earnings call

Vistagen Therapeutics Q3 2026 Earnings Call

Feb 12, 2026 2,991 words · 13 min read
  • Shawn SinghPresident and Chief Executive Officer
  • Joshua PrinceChief Operating Officer
  • Nick TresslerChief Financial Officer
  • Mark McPartlandVice President, Corporate Development and Investor Relations
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Vistagen Therapeutics Earnings Call Transcripts

Calls2
LatestFeb 12, 2026
SinceQ2 2026

Fiscal 2026

All 2 Vistagen Therapeutics transcripts Register to get access to Vistagen Therapeutics’s earnings call transcripts.

Vistagen Therapeutics Earnings Call Transcripts API

Pull Vistagen Therapeutics's earnings call transcripts - the full call, prepared remarks and the Q&A, speaker by speaker - into your own models and apps with the Business Quant Transcripts API. Add fyq (e.g. Q2 2025) for a given call. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/transcripts?ticker=VTGN&api_key=YOUR_API_KEY